These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8016993)

  • 21. [Improvement in leukocyte rheology with pentoxifylline].
    Matrai A; Ernst E
    Med Klin (Munich); 1988 Jan; 83(2):45-7. PubMed ID: 3352559
    [No Abstract]   [Full Text] [Related]  

  • 22. Pentoxifylline therapy for chronic claudication: are patients dependent on therapy?
    Johnson WC; Watkins MT; Hamilton J; Baldwin D; Walker N
    Surgery; 1994 Jun; 115(6):735-9. PubMed ID: 8197567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pentoxifylline for intermittent claudication. A critical review.
    Ernst E
    Angiology; 1994 May; 45(5):339-45. PubMed ID: 8172380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication.
    Dettelbach HR; Aviado DM
    J Clin Pharmacol; 1985; 25(1):8-26. PubMed ID: 3882773
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of pentoxifylline on carbohydrate metabolism in type II diabetics.
    Ambrus JL; Stadler S; Bannerman R
    Arch Intern Med; 1990 Apr; 150(4):921. PubMed ID: 2327862
    [No Abstract]   [Full Text] [Related]  

  • 26. [Vasonit retard in the treatment of intermittent claudication in patients with obliterating diseases of the lower extremities].
    Pokrovskiĭ AV; Chupin AV; Kalinin AA; Markosian AA; Zamskiĭ KS; Kolosov RV
    Angiol Sosud Khir; 2003; 9(2):19-24. PubMed ID: 12811370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial.
    De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
    Angiology; 2002; 53 Suppl 1():S13-7. PubMed ID: 11865829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks.
    Prescrire Int; 2009 Apr; 18(100):56-9. PubMed ID: 19585717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic results with xanthine derivatives in the intermittent claudication syndrome in diabetic patients].
    Gómez Reyes D; Rojas Hidalgo E
    Rev Clin Esp; 1988 Jan; 182(1):3-6. PubMed ID: 3375512
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacologic treatment of intermittent claudication with special emphasis on pentoxifylline.
    Hartshorn JC; Deans KW
    J Cardiovasc Nurs; 1987 Feb; 1(2):65-8. PubMed ID: 3646295
    [No Abstract]   [Full Text] [Related]  

  • 31. Pentoxifylline. A new drug review and case report.
    Pierce WL; Crowhurst JA; Caneva RG
    J Am Podiatr Med Assoc; 1986 Jul; 76(7):407-10. PubMed ID: 3723389
    [No Abstract]   [Full Text] [Related]  

  • 32. Pentoxifylline and intermittent claudication: review of clinical trials and cost-effectiveness analyses.
    Gillings DB
    J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S44-50. PubMed ID: 8699861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of response to pentoxifylline therapy in patients with intermittent claudication.
    Thomas JH; Swannack CJ; McAnaw M; Klein S; Kinnaman ML; Iliopoulos JI; Hermreck AS; Pierce GE
    Am J Surg; 1987 Dec; 154(6):663-5. PubMed ID: 3425814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The antagonist of type-II serotonin receptors naftidrofuryl in the treatment of patients with intermittent claudication].
    Komarov AL; Panchenko EP; Eshkeeva AR; Dobrovol'skiĭ AB; Titaeva EV; Karpov IuA
    Ter Arkh; 1996; 68(2):49-53. PubMed ID: 8771659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysing the analysis.
    Biron P
    CMAJ; 1997 Mar; 156(6):765-7. PubMed ID: 9084378
    [No Abstract]   [Full Text] [Related]  

  • 37. Short-range intermittent claudication and rest pain: microcirculatory effects of pentoxifylline in a randomized, controlled trial.
    Incandela L; De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Geroulakos G; Ramaswami G
    Angiology; 2002; 53 Suppl 1():S27-30. PubMed ID: 11865832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of severe intermittent claudication with pentoxifylline: a 40-week, controlled, randomized trial.
    Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; De Sanctis MT; Incandela L; Geroulakos G; Ramaswami G; Cazaubon M; Barsotti A; Vasdekis S; Bavera P; Ippolito E
    Angiology; 2002; 53 Suppl 1():S1-5. PubMed ID: 11865828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intermittent claudication: review of a disease of growing prevalence. II. Treatment].
    Riambau V; Piñol C
    Med Clin (Barc); 1998 Feb; 110(6):220-7. PubMed ID: 9580403
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug therapy in intermittent claudication: an objective assessment of the effects of three drugs on patients with intermittent claudication.
    Mashiah A; Patel P; Schraibman IG; Charlesworth D
    Br J Surg; 1978 May; 65(5):342-5. PubMed ID: 647201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.